Shenzhen Geno-Immune Medical Institute
2 clinical trials · 2 recruiting · OTHER
Trials by Shenzhen Geno-Immune Medical Institute
RECRUITINGPhase 1NCT06006741
Universal CAR-T Cells Targeting Multiple Myeloma
The aim of this study is to assess the feasibility, safety and efficacy of universal CAR T cells targeting multiple myeloma. Another goal of the study is to learn more about the...
Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 201 location
Multiple Myeloma in Remission
RECRUITINGNCT03727555
IT and IV Lentiviral Gene Therapy for X-ALD
This is a Phase I/II clinical trial of gene therapy for treating X-linked adrenoleukodystrophy using a high-safety, high-efficiency, self-inactivating lentiviral vector (LV)...
Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 301 location
X-linked Adrenoleukodystrophy